Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003147198 | SCV003833970 | uncertain significance | not provided | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004621765 | SCV005115809 | uncertain significance | Inborn genetic diseases | 2024-05-13 | criteria provided, single submitter | clinical testing | The c.10737C>A (p.D3579E) alteration is located in exon 9 (coding exon 9) of the FAT4 gene. This alteration results from a C to A substitution at nucleotide position 10737, causing the aspartic acid (D) at amino acid position 3579 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |